These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 23045627)

  • 21. Performance of the new HIV-1/2 diagnostic algorithm in Florida's public health testing population: a review of the first five months of utilization.
    Bennett B; Neumann D; Fordan S; Villaraza R; Crowe S; Gillis L
    J Clin Virol; 2013 Dec; 58 Suppl 1():e29-33. PubMed ID: 24342476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Field evaluation of the Abbott ARCHITECT HIV Ag/Ab Combo immunoassay.
    Kfutwah A; Lemée V; Ngono HV; De Oliveira F; Njouom R; Plantier JC
    J Clin Virol; 2013 Dec; 58 Suppl 1():e70-5. PubMed ID: 24342480
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Performance of Determine Combo and other point-of-care HIV tests among Seattle MSM.
    Stekler JD; Ure G; O'Neal JD; Lane A; Swanson F; Maenza J; Stevens C; Coombs RW; Dragavon J; Swenson PD; Golden MR
    J Clin Virol; 2016 Mar; 76():8-13. PubMed ID: 26774543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fourth-generation enzyme immunoassays for screening of HIV in blood donors: need of the hour.
    Kaur R; Basu S; Kaur G; Singh D
    Indian J Pathol Microbiol; 2011; 54(2):433-4. PubMed ID: 21623129
    [No Abstract]   [Full Text] [Related]  

  • 25. Evaluation of two 4th generation point-of-care assays for the detection of Human Immunodeficiency Virus infection.
    Stafylis C; Klausner JD
    PLoS One; 2017; 12(8):e0183944. PubMed ID: 28846743
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the performance of a new automated HIV combination assay.
    Ghisetti V; Coignard C; Allice T; Thoai Duong L
    J Clin Virol; 2017 Nov; 96():80-83. PubMed ID: 29020658
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A prospective multicentre study of healthcare provider preference in rapid HIV testing kits: Determine versus INSTI.
    Amyai N; Darling K; D'Acremont V; Castro E; Ebert S; Diserens MM; Perdrix J; Fossati AH; Bodenmann P; Cavassini M
    Int J STD AIDS; 2018 Jan; 29(1):51-56. PubMed ID: 28669324
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Performance evaluation of the ADVIA Centaur(®) HIV Ag/Ab Combo assay.
    Pumarola T; Freeman J; Saxton E; Dillon P; Bal T; van Helden J
    J Virol Methods; 2010 Dec; 170(1-2):16-20. PubMed ID: 20723562
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of five simple rapid HIV assays for potential use in the Brazilian national HIV testing algorithm.
    da Motta LR; Vanni AC; Kato SK; Borges LG; Sperhacke RD; Ribeiro RM; Inocêncio LA;
    J Virol Methods; 2013 Dec; 194(1-2):132-7. PubMed ID: 23994148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative evaluation of three FDA-approved HIV Ag/Ab combination tests using a genetically diverse HIV panel and diagnostic specimens.
    Qiu X; Sokoll L; Yip P; Elliott DJ; Dua R; Mohr P; Wang XY; Spencer M; Swanson P; Dawson GJ; Hackett J
    J Clin Virol; 2017 Jul; 92():62-68. PubMed ID: 28535437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ARCHITECT® HIV Ag/Ab Combo assay: correlation of HIV-1 p24 antigen sensitivity and RNA viral load using genetically diverse virus isolates.
    Brennan CA; Yamaguchi J; Vallari A; Swanson P; Hackett JR
    J Clin Virol; 2013 Jun; 57(2):169-72. PubMed ID: 23485348
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the accuracy and ease of use of a rapid HIV-1 Antibody Test performed by untrained operators at the point of care.
    Galli RA; Green KF; La Marca A; Waldman LF; Powers RE; Daly AC; Shackleton CR
    J Clin Virol; 2013 Dec; 58 Suppl 1():e65-9. PubMed ID: 24342479
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Performance evaluation of the Bio-Rad Laboratories GS HIV Combo Ag/Ab EIA, a 4th generation HIV assay for the simultaneous detection of HIV p24 antigen and antibodies to HIV-1 (groups M and O) and HIV-2 in human serum or plasma.
    Bentsen C; McLaughlin L; Mitchell E; Ferrera C; Liska S; Myers R; Peel S; Swenson P; Gadelle S; Shriver MK
    J Clin Virol; 2011 Dec; 52 Suppl 1():S57-61. PubMed ID: 21995929
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Performance of the Liaison XL Murex HIV Ab/Ag test on clinical samples representing current epidemic HIV variants.
    Lemee V; Leoz M; Etienne M; De Oliveira F; Plantier JC
    J Clin Microbiol; 2014 Sep; 52(9):3277-9. PubMed ID: 24966360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of the Abbott Architect HIV antigen/antibody assay in a low incidence population.
    Dubravac T; Gahan TF; Pentella MA
    J Clin Virol; 2013 Dec; 58 Suppl 1():e76-8. PubMed ID: 24342481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of a rapid and simple fourth-generation HIV screening assay for qualitative detection of HIV p24 antigen and/or antibodies to HIV-1 and HIV-2.
    Beelaert G; Fransen K
    J Virol Methods; 2010 Sep; 168(1-2):218-22. PubMed ID: 20561542
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Performance of rapid tests for discrimination between HIV-1 and/or HIV-2 infections.
    Gautheret-Dejean A; Bocobza J; Brunet S; Damond F; Plantier JC; Barin F
    J Med Virol; 2015 Dec; 87(12):2061-6. PubMed ID: 26081750
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute HIV infection: improved algorithms for HIV testing.
    Ghisetti V; Calcagno A; Burdino E; Orofino G; Bonora S
    J Clin Virol; 2015 Feb; 63():51-2. PubMed ID: 25600605
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical performance of the novel DiaSorin LIAISON(®) XL murex: HBsAg Quant, HCV-Ab, HIV-Ab/Ag assays.
    Krawczyk A; Hintze C; Ackermann J; Goitowski B; Trippler M; Grüner N; Neumann-Fraune M; Verheyen J; Fiedler M
    J Clin Virol; 2014 Jan; 59(1):44-9. PubMed ID: 24268764
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A signal-to-cutoff ratio in the Abbott architect HIV Ag/Ab Combo assay that predicts subsequent confirmation of HIV-1 infection in a low-prevalence setting.
    Jensen TO; Robertson P; Whybin R; Chambers I; Lahra M; Rawlinson W; Post JJ
    J Clin Microbiol; 2015 May; 53(5):1709-11. PubMed ID: 25673794
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.